MedDataX Logo

BPA Levels Relationship With IVF/ICSI Outcomes in Low Ovarian Reserve

NCT ID: NCT04654598

Last Updated: 2020-12-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

74 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-01

Study Completion Date

2019-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The relationship between BPA elevation in urine, blood, and follicle fluid and embryo quality, IVF/ICSI outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility Low Over Reserve IVF Infertility, Female

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

BPA level

BPA (bisphenol A) in urine, blood and follicle fluid samples

Group Type OTHER

BPA levels

Intervention Type OTHER

BPA (bisphenol A) in urine, blood and follicle fluid samples

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

BPA levels

BPA (bisphenol A) in urine, blood and follicle fluid samples

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients who underwent IVF due to low ovarian reserve
* patients provided urine, blood, and follicle fluid (FF) samples on the oocyte retrieval day
* patients who did not smoke or use alcohol
* patients did not work in the plastic industry

Exclusion Criteria

* patients who underwent IVF due to unexplained infertility or tubal factor or male factor indications
* patients diagnosed with endometriosis
* patients with freeze-all cycles
* patients having previous ovarian surgery
* women with metabolic disease (such as hypertension or diabetes mellitus)
* patients with a known genetic problem (male or female)
Minimum Eligible Age

25 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nefise Nazlı YENIGUL

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nefise Nazlı YENIGUL

Ph.D. Assistant Professor, Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nefise Nazlı YENIGUL

Sanliurfa, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019/19

Identifier Type: -

Identifier Source: org_study_id